Gabather AB (publ)
Gabather AB (publ), a pharmaceutical company, develops drug candidates for the treatment of central nervous system diseases. The company offers drugs primarily in the areas of anti-psychotics, anti-depressants and anxiolytics, and analgesics, as well as cognition-enhancing treatments, including Alzheimer's disease. It focuses on developing GT-002, a pro-cognitive drug candidate for the treatment … Read more
Gabather AB (publ) (GABA) - Total Assets
Latest total assets as of September 2025: Skr1.36 Million SEK
Based on the latest financial reports, Gabather AB (publ) (GABA) holds total assets worth Skr1.36 Million SEK as of September 2025.
Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments.
Gabather AB (publ) - Total Assets Trend (2014–2024)
This chart illustrates how Gabather AB (publ)’s total assets have evolved over time, based on quarterly financial data. Explore and compare other companies by total assets.
Gabather AB (publ) - Asset Composition Analysis
Current Asset Composition (December 2024)
Gabather AB (publ)'s total assets of Skr1.36 Million consist of 97.3% current assets and 2.7% non-current assets.
| Asset Category | Amount (SEK) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | Skr878.00K | 47.9% |
| Accounts Receivable | Skr800.00K | 43.6% |
| Inventory | Skr0.00 | 0.0% |
| Property, Plant & Equipment | Skr0.00 | 0.0% |
| Intangible Assets | Skr0.00 | 0.0% |
| Goodwill | Skr0.00 | 0.0% |
Asset Composition Trend (2014–2024)
This chart illustrates how Gabather AB (publ)'s asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Gabather AB (publ)'s current assets represent 97.3% of total assets in 2024, an increase from 93.0% in 2014.
- Cash Position: Cash and equivalents constituted 47.9% of total assets in 2024, down from 87.1% in 2014.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 0.0% of total assets, a decrease from 6.0% in 2014.
- Asset Diversification: The largest asset category is cash and equivalents at 47.9% of total assets.
Gabather AB (publ) Competitors by Total Assets
Key competitors of Gabather AB (publ) based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Swedish Orphan Biovitrum AB (publ)
PINK:BIOVF
|
USA | $67.26 Billion |
|
Kamada
NASDAQ:KMDA
|
USA | $378.79 Million |
|
One World Pharma Inc
OTCQB:OWPC
|
USA | $6.62 Million |
|
Dongwha Pharm.Co.Ltd
KO:000020
|
Korea | ₩654.63 Billion |
|
Shenzhen Neptunus Bioengineering Co Ltd
SHE:000078
|
China | CN¥27.28 Billion |
|
Yuhan Corp.
KO:000100
|
Korea | ₩3.05 Trillion |
|
Anhui Fengyuan Pharmaceutical Co Ltd
SHE:000153
|
China | CN¥4.97 Billion |
|
Kotra Industries Bhd
KLSE:0002
|
Malaysia | RM363.90 Million |
Gabather AB (publ) - Asset Efficiency Metrics
Asset efficiency metrics measure how effectively a company uses its assets to generate revenue and profits. These indicators help investors evaluate management's ability to deploy capital efficiently.
Asset Turnover Ratio
Measures how efficiently a company uses its assets to generate sales
Lower asset utilization - Gabather AB (publ) generates 0.00x its asset value in annual revenue.
Return on Assets (ROA)
Measures how efficiently a company uses its assets to generate profits
Negative ROA - Gabather AB (publ) is currently not profitable relative to its asset base.
Gabather AB (publ) - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 0.33 | 0.52 | 9.42 |
| Quick Ratio | 0.33 | 0.52 | 9.49 |
| Cash Ratio | 0.23 | 0.37 | 0.00 |
| Working Capital | Skr-2.66 Million | Skr -2.75 Million | Skr 27.86 Million |
Gabather AB (publ) - Advanced Valuation Insights
This section examines the relationship between Gabather AB (publ)'s asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 28.77 |
| Latest Market Cap to Assets Ratio | 0.40 |
| Asset Growth Rate (YoY) | -75.1% |
| Total Assets | Skr1.83 Million |
| Market Capitalization | $732.74K USD |
Valuation Analysis
Below Book Valuation: The market values Gabather AB (publ)'s assets below their book value (0.40 x), which may indicate investor concerns about asset quality or future growth.
Significant Asset Reduction: Gabather AB (publ)'s assets decreased by 75.1% over the past year, potentially indicating divestiture, restructuring, or challenging business conditions.
Annual Total Assets for Gabather AB (publ) (2014–2024)
The table below shows the annual total assets of Gabather AB (publ) from 2014 to 2024.
| Year | Total Assets | Change |
|---|---|---|
| 2024-12-31 | Skr1.83 Million | -75.11% |
| 2023-12-31 | Skr7.36 Million | +9.06% |
| 2022-12-31 | Skr6.75 Million | -56.13% |
| 2021-12-31 | Skr15.39 Million | -52.14% |
| 2020-12-31 | Skr32.16 Million | -30.19% |
| 2019-12-31 | Skr46.07 Million | +153.66% |
| 2018-12-31 | Skr18.16 Million | -62.30% |
| 2017-12-31 | Skr48.18 Million | +38.66% |
| 2016-12-31 | Skr34.75 Million | +157.14% |
| 2015-12-31 | Skr13.51 Million | +47.51% |
| 2014-12-31 | Skr9.16 Million | -- |